Stimulation of gluconeogenesis by intravenous lipids in preterm infants: Response depends on fatty acid profile

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 4, 2006, Pages

  Van Kempen, Anne A M W ^a   Van Der Crabben, Saskia N ^a   Ackermans, Mariëtte T ^a,b   Endert, Erik ^a,b   Kok, Joke H ^a   Sauerwein, Hans P ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Fatty acids unsaturated; Glycerol; Mass isotopomer distribution analysis; Stable isotopes

Indexed keywords

FATTY ACID; INSULIN; LIPID EMULSION; TRIACYLGLYCEROL; GLUCOSE; LIPID;

ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLYCEROL BLOOD LEVEL; HUMAN; INFANT; INSULIN BLOOD LEVEL; PREMATURITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; KINETICS; MALE; METABOLISM; NEWBORN; PHYSIOLOGY;

FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCONEOGENESIS; GLUCOSE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN; KINETICS; LIPIDS; MALE; TRIGLYCERIDES;

EID: 33646089440     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00303.2005     Document Type: Article

References (55)

1. 13C]glycerol. J Clin Endocrinol Metab 86: 2220-2226, 2001.
2. Aiston S, Green A, Mukhtar M, and Agius L. Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose. Biochem J 377: 195-204, 2004.
3. Allick G, Sprangers F, Weverling GJ, Ackermans MT, Meijer AJ, Romijn JA, Endert E, Bisschop PH, and Sauerwein HP. Free fatty acids increase hepatic glycogen content in obese males. Metabolism 53: 886-893, 2004.
4. Alstrup K, Gregersen S, Jensen H, Thomsen J, and Hermansen K. Differential effects of cis and trans fatty acids on insulin release from isolated mouse islets. Metabolism 48: 22-29, 1999.
5. Antras-Ferry J, Le Bigot G, Robin P, Robin D, and Forest C. Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids. Biochem Biophys Res Commun 203: 385-391, 1994.
6. Bahl JJ, Matsuda M, DeFronzo RA, and Bressler R. In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase. Biochem Pharmacol 53: 67-74, 1997.
7. Barthel A and Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285: E685-E692, 2003.
8. Beysen C, Karpe F, Fielding BA, Clark A, Levy JC, and Frayn KN. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 45: 1533-1541, 2002.
9. Boden G, Chen X, and Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 47: 1609-1612, 1998.
10. Boden G, Chen X, Capulong E, and Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50: 810-816, 2001.
11. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
12. Bougnères PF, Castaño L, Rocchiccioli F, Pham Gia H, Leluyer B, and Ferré P. Medium-chain fatty acids increase glucose production in normal and low birth weight newborns. Am J Physiol Endocrinol Metab 256: E692-E697, 1989.
13. Chen X, Iqbal N, and Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
14. Chu CA, Sherck SM, Igawa K, Sindelar DK, Neal DW, Emshwiller M, and Cherrington AD. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am J Physiol Endocrinol Metab 282: E402-E411, 2002.
15. Clore JN, Allred J, White D, Li J, and Stillman J. The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus. Metabolism 51: 1471-1477, 2002.
16. Clore JN, Glickman PS, Nestler JE, and Blackard WG. In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol Endocrinol Metab 261: E425-E429, 1991.
17. Cooke RJ, Yeh YY, Gibson D, Debo D, and Bell GL. Soybean oil emulsion administration during parenteral nutrition in the preterm infant: effect on essential fatty acid, lipid, and glucose metabolism. J Pediatr 111: 767-773, 1987.
18. Corssmit EP, Stouthard JM, Romijn JA, Endert E, and Sauerwein HP. Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives. Metabolism 43: 1503-1508, 1994.
19. Cowett RM and Farrag H. Neonatal glucose metabolism. In: Principles of Perinatal-Neonatal Metabolism, edited by Cowett RM. New York: Springer Verlag, 1998.
20. Cowett RM and Farrag HM. Selected principles of perinatal-neonatal glucose metabolism. Semin Neonatol 9: 37-47, 2004.
21. Edgerton DS, Cardin S, Emshwiller M, Neal D, Chandramouli V, Schumann WC, Landau BR, Rossetti L, and Cherrington AD. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes 50: 1872-1882, 2001.
22. Groth T, Ewald U, and Gustafsson J. Errors in estimating neonatal production of glucose with stable isotopes during "approximate steady state". Scand J Clin Lab Invest 61: 663-680, 2001.
23. Gustafson LA, Neeft M, Reijngoud DJ, Kuipers F, Sauerwein HP, Romijn JA, Herling AW, Burger HJ, and Meijer AJ. Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes. Biochem J 358: 665-671, 2001.
24. Hawdon JM, Aynsley-Green A, and Ward Platt MP. Neonatal blood glucose concentrations: metabolic effects of intravenous glucagon end intragastric medium chain triglyceride. Arch Dis Child 68: 255-261, 1993.
25. Hellerstein MK and Neese RA. Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. Am J Physiol Endocrinol Metab 263: E988-E1001, 1992.
26. Hertz DE, Karn CA, Liu YM, Liechty EA, and Denne SC. Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns. J Clin Invest 92: 1752-1758, 1993.
27. Kloosterman GJ. On intrauterine growth. Int J Gynaecol Obstet 8: 895-912, 1970.
28. Kolb H and Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 48: 1038-1050, 2005.
29. Lafeber HN, Sulkers EJ, Chapman TE, and Sauer PJ. Glucose production and oxidation in preterm infants during total parenteral nutrition. Pediatr Res 28: 153-157, 1990.
30. Lam TK, Carpentier A, Lewis GF, van de Werve G, Fantus IG, and Giacca A. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284: E863-E873, 2003.
31. Mashek DG and Grummer RR. Effects of long chain fatty acids on lipid and glucose metabolism in monolayer cultures of bovine hepatocytes. J Dairy Sci 86: 2390-2396, 2003.
32. Mashek DG, Bertics SJ, and Grummer RR. Metabolic fate of long-chain unsaturated fatty acids and their effects on palmitic acid metabolism and gluconeogenesis in bovine hepatocytes. J Dairy Sci 85: 2283-2289, 2002.
33. Massillon D, Barzilai N, Hawkins M, Prus-Wertheimer D, and Rossetti L. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46: 153-157, 1997.
34. Moore MC, Connolly CC, and Cherrington AD. Autoregulation of hepatic glucose production. Eur J Endocrinol 138: 240-248, 1998.
35. Neese RA, Schwartz JM, Faix D, Turner S, Letscher A, Vu D, and Hellerstein MK. Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. J Biol Chem 270: 14452-14466, 1995.
36. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhausl W, and Shulman GI. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49: 701-707, 2000.
37. Sabel KG, Olegard R, Mellander M, and Hildingsson K. Interrelation between fatty acid oxidation and control of gluconeogenic substrates in small-for-gestational-age (SGA) infants with hypoglycemia and with normoglycemia. Acta Paediatr Scand 71: 53-61, 1982.
38. Sann L, Divry P, Lasne Y, and Ruitton A. Effect of oral lipid administration on glucose homeostasis in small-for-gestational-age infants. Acta Paediatr Scand 71: 923-927, 1982.
39. Sann L, Mathieu M, Lasne Y, and Ruitton A. Effect of oral administration of lipids with 67% medium chain triglycerides on glucose homeostasis in preterm neonates. Metabolism 30: 712-716, 1981.
40. Sann L, Mousson B, Rousson M, Maire I, and Bethenod M. Prevention of neonatal hypoglycemia by oral lipid supplementation in low birth weight infants. Eur J Pediatr 147: 158-161, 1988.
41. Savich RD, Finley SL, and Ogata ES. Intravenous lipid and amino acids briskly increase plasma glucose concentration in small premature infants. Am J Perinatol 5: 201-205, 1988.
42. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ, and Beck-Nielsen H. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52: 260-267, 2003.
43. Stahl GE, Spear ML, and Hamosh M. Physiologic effects of lipid infusions. In: Fetal and Neonatal Physiology, edited by Polin RA and Fox WW. Philadelphia, PA: Saunders, 1998.
44. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420-430, 1959.
45. Stein D, Stevenson B, Chester M, Basit M, Daniels M, Turley S, and McGarry J. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100: 398-403, 1997.
46. Stingl H, Krššák M, Krebs M, Bischof MG, Nowotny P, Fürnsinn C, Shulman GI, Waldhäusl W, and Roden M. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 44: 48-54, 2001.
47. Sunehag AL. Parenteral glycerol enhances gluconeogenesis in very premature infants. Pediatr Res 53: 635-641, 2003.
48. Sunehag AL. The role of parenteral lipids in supporting gluconeogenesis in very premature infants. Pediatr Res 54: 480-486, 2003.
49. van Kempen AA, Romijn JA, Ruiter AF, Ackermans MT, Endert E, Hoekstra JH, Kok JH, and Sauerwein HP. Adaptation of glucose production and gluconeogenesis to diminishing glucose infusion in preterm infants at varying gestational ages. Pediatr Res 53: 628-634, 2003.
50. Versleijen M, Roelofs H, Preijers F, Roos D, and Wanten G. Parenteral lipids modulate leukocyte phenotypes in whole blood, depending on their fatty acid composition. Clin Nutr 24: 822-829, 2005.
51. Vileisis RA, Cowett RM, and Oh W. Glycemic response to lipid infusion in the premature neonate. J Pediatr 100: 108-112, 1982.
52. Warnotte C, Nenquin M, and Henquin JC. Unbound rather than total concentrations and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion. Mol Cell Endocrinol 153: 147-153, 1999.
53. Williamson J, Browning E, and Scholz R. Control mechanisms of gluconeogenesis and ketogenesis. J Biol Chem 224: 4607-4616, 1969.
54. Williamson JR, Kreisberg RA, and Felts PW. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56: 247-254, 1966.
55. Yunis KA, Oh W, Kalhan S, and Cowett RM. Glucose kinetics following administration of an intravenous fat emulsion to low-birth-weight neonates. Am J Physiol Endocrinol Metab 263: E844 -E849, 1992.